SLDB - Solid Biosciences - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

SLDB is currently covered by 4 analysts with an average potential upside of $13.04 (18.94%) from yesterday's end of day stock price of $5.06. Solid Biosciences activity chart has currently 14 price targets and 36 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.5% with an average time for these price targets to be met of 106.1 days.

Highest price target for SLDB is $15, Lowest price target is $7, average price target is $11.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 11-Nov-2022. First documented stock forecast 20-Feb-2018.

Currently, out of the existing stock ratings of SLDB - 5 which are a Hold (71.43%), 2 which are a Buy (28.57%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$5.9 (280.95%)


1 years 29 days ago

0/3 (0%)

$34.71 (56.34%)


1 years 1 months 23 days ago

2/2 (100%)

$12.15 (11.27%)




1 years 2 months 10 days ago

2/2 (100%)

$-4.8 (-3.43%)




$-0.96 (-13.79%)


1 years 3 months 28 days ago

4/4 (100%)

$-12.32 (-45.04%)



1 years 6 months 21 days ago

0/1 (0%)

$41.1 (84.05%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SLDB (Solid Biosciences) average time for price targets to be met?

On average it took 106.1 days on average for the stock forecasts to be realized with a an average price target met ratio 69.5

Which analyst has the current highest performing score on SLDB (Solid Biosciences) with a proven track record?


Which analyst has the most public recommendations on SLDB (Solid Biosciences)?

Joseph Schwartz works at LEERINK and has 1 price targets and 2 ratings on SLDB

Which analyst is the currently most bullish on SLDB (Solid Biosciences)?

Martin Auster with highest potential upside - $117.9

Which analyst is the currently most reserved on SLDB (Solid Biosciences)?

Geulah Livshits with lowest potential downside - -$0.96

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart